Sort by:
40 products
40 products
Patector Rosa N.F. Injectable Solution
Comparable to:
Active ingredient: Nandrolone Phenylpropionate / Estradiol
Concentration: 75/5mg
Presentation: Injectable Solution
Laboratory: PATECTOR
Origin: Made in Mexico
Patector Rosa N.F. is an injectable solution that combines nandrolone phenylpropionate and estradiol, indicated for hormone replacement therapy. Nandrolone helps improve muscle mass, bone density, and overall well-being, while estradiol contributes to hormonal balance. Used in specific treatments under strict medical supervision for conditions requiring combined hormonal supplementation.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
PERLUDIL (ALGESTONE / ESTRADIOL) Injection 1 mL
Comparable to: Perludil
Active ingredient: Algestone / Estradiol
Presentation: Box with 1 ampoule of 1 mL
Laboratory: Collins
Origin: Mexico
This medication is used as a long-acting injectable hormonal contraceptive. The combination of algestone and estradiol works by inhibiting ovulation and producing hormonal changes that help prevent pregnancy.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
PRESERVATIVO TROJAN PIEL DESNUDA C/3 PIEZAS
Descripción del producto:
Condones Trojan Piel Desnuda diseñados para ofrecer una sensación más natural y cercana al contacto real. Fabricados con látex de alta calidad, lubricados para mayor comodidad y placer durante el uso.
Especificaciones técnicas:
• Contenido: 3 piezas por caja
• Material: Látex natural de alta calidad
• Lubricación: Prelubricados
• Característica: Diseño ultrafino para sensación piel con piel
• Presentación: Caja individual
Indicaciones de uso:
Para uso como método anticonceptivo y protección contra infecciones de transmisión sexual. Usar correctamente en cada relación sexual. Almacenar en lugar fresco y seco, alejado de la luz solar directa. Verificar fecha de caducidad antes de usar. Para uso exclusivo en adultos.
Fabricante: Church & Dwight
El consumo de este producto es responsabilidad de quien lo recomienda y quien lo usa. Consulte a su médico ante cualquier duda.
Prevepost 50/5 mg
Active ingredient: Norethisterone / Estradiol
Concentration: 50 mg / 5 mg per ml
Presentation: Injectable solution, box with 1 ampoule-syringe of 1 ml
Route of administration: Intramuscular
This medication is a monthly injectable hormonal contraceptive that combines a progestogen (norethisterone) and an estrogen (estradiol), used for pregnancy prevention.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
RADIANCE (DROSPIRENONE / ETHINYLESTRADIOL)
Comparable to: Radiance
Active ingredient: Drospirenone / Ethinylestradiol
Presentation: Box with 28 tablets
Laboratory: Liomont
Origin: Mexico
This combined oral contraceptive medication is used to prevent pregnancy. The combination of drospirenone and ethinylestradiol helps inhibit ovulation, thicken cervical mucus, and modify the endometrium, decreasing the likelihood of conception when used correctly as directed by a doctor.
The consumption of this product is the responsibility of whoever recommends and whoever uses it. Consult your doctor before consuming any medication.
Oral contraceptive with antiandrogenic effects antimineralocorticoid and also beneficial for women with fluid retention of hormone and the resulting symptoms and women with acne and seborrhea.
CONTRAINDICATIONS: Do not use oral contraceptives (COCs) in the presence of any of the situations listed below. Must cease immediately the use of prepared if any of them for the first first time during his employment:
• Presence or history of thrombotic / thromboembolic arterial or venous (eg, deep vein thrombosis, pulmonary embolism, myocardial infarction) or stroke.
• Presence or history of prodrome of a thrombosis (eg transient ischemic attack, angina pectoris).
• History of migraine with focal neurological symptoms.
• Diabetes mellitus with vascular involvement.
• The presence of a serious risk factor or multiple risk factors for arterial or venous thrombosis may also constitute a contraindication (see Precautions).
• Presence or history of pancreatitis if it is associated with hypertriglyceridemia.
• Presence or history of severe liver disease while the liver function values have not returned to normal.
• severe renal insufficiency or acute renal failure.
• Presence or history of liver tumors (benign or malignant).
• known or suspected neoplasms, influenced by sex steroids (for example, of the genitals or the breasts).
• Undiagnosed vaginal bleeding.
• Pregnancy known or suspected.
• Hypersensitivity to the active substances or any of the excipients.
RESTRICTIONS OF USE DURING PREGNANCY AND LACTATION: RADIANCE is not indicated during pregnancy. If a woman becomes pregnant while taking RADIANCE, discontinue administration.
However, epidemiological studies on a large scale have not revealed an increased risk of birth defects in children of mothers who used COCs prior to pregnancy or a teratogenic effect when COCs were taken inadvertently during early pregnancy.
The available data on the use of Yasmin ® during pregnancy are too limited to draw conclusions about the negative effects of Yasmin ® about pregnancy, health of the fetus or the newborn. Not yet available relevant epidemiological data.
Breastfeeding can be affected by the AOC, as they may reduce the amount of milk and alter its composition and therefore should not be recommended in general the use of AOC until the mother has not completely stopped breastfeeding. Small amounts of contraceptive steroids and / or its metabolites can be eliminated by milk.
DOSAGE AND ADMINISTRATION:
How to take RADIANCE: If taken properly, COCs have a failure rate of about 1% per year. This failure rate may increase if you forget or incorrect taking the pill. The tablets should be taken in the order indicated on the package every day at about the same time, with a little liquid if necessary. It will take a tablet daily for 21 consecutive days. Each package will start back after an interval of 7 days without pills, which usually occur during a withdrawal bleed.The bleeding usually begin 2-3 days after taking the last pill, and you may not have finished where appropriate to start the next pack
RADIANCE
Comparable to: Yasminelle
Active ingredient: Drospirenone, Ethinylestradiol
Concentration: 3MG/20MCG
Presentation: 28 TABLETS
Laboratory: LIOMONT
Origin: Made in Mexico
Low-dose combined oral contraceptive, formulated to prevent pregnancy and offer additional benefits. It works by suppressing ovulation and modifying uterine conditions. Its composition with Drospirenone can help control fluid retention, acne, and seborrhea, contributing to better skin and overall well-being.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Levonorgestrel 0.15 mg / Ethinylestradiol 0.03 mg
Comparable to: Microgynon
Active ingredient: Levonorgestrel / Ethinylestradiol
Concentration: 0.15 mg / 0.03 mg per tablet
Presentation: Box with 21 tablets
Laboratory: Farmacéutica Hispanoamericana
Origin: Made in Mexico
This generic medication is used as an oral contraceptive for pregnancy prevention. Its formulation ensures a reliable and effective option for birth control, backed by local quality standards. Ideal for those seeking an accessible alternative without compromising efficacy.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
SEGFEMIOL (LEVONORGESTREL / ETHINYL ESTRADIOL) 28 TABLETS 0.15/0.03MG
SEGFEMIOL (LEVONORGESTREL / ETHINYL ESTRADIOL) 28 TABLETS 0.15/0.03MG
SEGFEMIOL
Comparable to: Microgynon
Active substance: LEVONORGESTREL / ETHINYLESTRADIOL
Concentration: 0.15/0.03MG
Presentation: C/28 TABS
Laboratory: FARMACEUTICA HISPANOAMERICANA
Origin: Made in Mexico
SEGFEMIOL is a combined oral contraceptive for regular pregnancy prevention. Its formula with levonorgestrel and ethinylestradiol inhibits ovulation, thickens cervical mucus, and modifies the endometrium, making conception difficult. It offers regular cycles and consistent hormonal control.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
SILOGIN
Comparable to: Glanique
Active ingredient: Levonorgestrel
Concentration: 0.75mg
Presentation: 2 tablets
Manufacturer: PERRIGO
Origin: Made in Mexico
SILOGIN is an emergency contraceptive used to prevent pregnancy after unprotected sex. It contains levonorgestrel, which primarily works by delaying or inhibiting ovulation. For maximum effectiveness, it should be taken as soon as possible after intercourse, within 72 hours.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
TRIQUILAR
Comparable to: Triquilar
Active ingredient: LEVONORGESTREL / ETHINYL ESTRADIOL
Concentration: Not specified
Presentation: 21 DRAGEES
Laboratory: ASOFARMA
Origin: Made in Mexico
TRIQUILAR is a triphasic oral contraceptive that prevents pregnancy by mimicking the natural hormonal variations of the menstrual cycle. It works by inhibiting ovulation, modifying cervical mucus, and altering the uterine lining. It provides high contraceptive efficacy and contributes to regular cycles.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
YASMIN (DROSPIRENONE / ETHINYL ESTRADIOL)
Comparable to: Yasmin
Active substance: Drospirenone / Ethinyl Estradiol
Concentration: 3 mg / 0.03 mg per tablet
Presentation: Box with 21 tablets
Laboratory: BAYER
Origin: Mexico
Yasmin is a combined oral contraceptive medication used to prevent pregnancy. Drospirenone and ethinyl estradiol work together to inhibit ovulation, alter cervical mucus, and modify the endometrium, thereby reducing the likelihood of conception.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Oral contraceptive with antiandrogenic effects antimineralocorticoid and also beneficial for women with fluid retention of hormone and the resulting symptoms and women with acne and seborrhea.
CONTRAINDICATIONS: Do not use oral contraceptives (COCs) in the presence of any of the situations listed below. Must cease immediately the use of prepared if any of them for the first time during his employment:
• Presence or history of thrombotic / thromboembolic arterial or venous (eg, deep vein thrombosis, pulmonary embolism, myocardial infarction) or stroke.
• Presence or history of prodrome of a thrombosis (eg transient ischemic attack, angina pectoris).
• History of migraine with focal neurological symptoms.
• Diabetes mellitus with vascular involvement.
• The presence of a serious risk factor or multiple risk factors for arterial or venous thrombosis may also constitute a contraindication (see Precautions).
• Presence or history of pancreatitis if it is associated with hypertriglyceridemia.
• Presence or history of severe liver disease while the liver function values have not returned to normal.
• severe renal insufficiency or acute renal failure.
• Presence or history of liver tumors (benign or malignant).
• known or suspected neoplasms, influenced by sex steroids (for example, of the genitals or the breasts).
• Undiagnosed vaginal bleeding.
• Pregnancy known or suspected.
• Hypersensitivity to the active substances or any of the excipients.
RESTRICTIONS OF USE DURING PREGNANCY AND LACTATION: YASMIN ® is not indicated during pregnancy. If a woman becomes pregnant while taking YASMIN ®, discontinue administration.
However, epidemiological studies on a large scale have not revealed an increased risk of birth defects in children of mothers who used COCs prior to pregnancy or a teratogenic effect when COCs were taken inadvertently during early pregnancy.
The available data on the use of Yasmin ® during pregnancy are too limited to draw conclusions about the negative effects of Yasmin ® about pregnancy, health of the fetus or the newborn. Not yet available relevant epidemiological data.
Breastfeeding can be affected by the AOC, as they may reduce the amount of milk and alter its composition and therefore should not be recommended in general the use of AOC until the mother has not completely stopped breastfeeding. Small amounts of contraceptive steroids and / or its metabolites can be eliminated by milk.
DOSAGE AND ADMINISTRATION:
How to take Yasmin ®: If taken properly, combined oral contraceptives have a failure rate of about 1% per year. This failure rate may increase if you forget or take the pill incorrectly. Thetablets should be taken in the order indicated on the package every day at about the same time with a little liquid if necessary. It will take one tablet daily for 21 consecutive days. Each package will start back after an interval of 7 days without pills, which usually occurs during a withdrawal bleed. The bleeding usually begin 2-3 days after taking the last tablet and may not have finished where appropriate to start the next pack.
YASMIN 24/4 (DROSPIRENONE / ETHINYL ESTRADIOL)
Comparable to: Yasmin
Active substance: Drospirenone / Ethinyl Estradiol
Concentration: 3 mg / 0.03 mg per tablet
Presentation: Box with 28 tablets (24 active + 4 inactive)
Laboratory: Bayer de Mexico
Origin: Mexico
Yasmin 24/4 is a combined oral contraceptive medication used to prevent pregnancy. The formulation of 24 active and 4 inactive tablets maintains more constant hormone levels throughout the cycle, helping to inhibit ovulation, thicken cervical mucus, and modify the endometrium, thereby reducing the probability of conception.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.

{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>